Signal active
Organization
Contact Information
Overview
Acclinate is a health tech company on a mission to revolutionize clinical trials. Acclinate specializes in engaging communities of color and increasing diversity in clinical trials, addressing a significant health equity issue. Their approach combines sustained community engagement with advanced AI/ML technology.
About
Health Care, Pharmaceutical, Biopharma
2020
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Acclinate headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Biopharma sector. The company focuses on Health Care and has secured $1.1B in funding across 84 round(s). With a team of 1-10 employees, Acclinate is actively contributing to advancements in Health Care. Their latest funding round, Series A - Acclinate, raised $7.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
7
3
0
$13.5M
Details
5
Acclinate has raised a total of $13.5M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | |||
2021 | Seed | 1.4M | ||
2022 | Seed | 4.9M | ||
2024 | Early Stage Venture | 7.0M |
Investors
Acclinate is funded by 29 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Acclinate | - | FUNDING ROUND - Acclinate | 7.0M |
Cencora Ventures | - | FUNDING ROUND - Cencora Ventures | 7.0M |
Acclinate | - | FUNDING ROUND - Acclinate | 7.0M |
LabCorp | - | FUNDING ROUND - LabCorp | 7.0M |
Recent Activity
There is no recent news or activity for this profile.